Mangalam Drugs and Organics Share Price

Approval for the appointment of Shri Prabhakar Raghunath Zavar as an Independent Director (Non Executive Director) of the Company for term of 5 years , who has attained age of 78 years.

• BSE India
• 5 hours ago

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMangalam Drugs & Organics Ltd 2CIN NO.L24230MH1972PLC116413 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 7.50 4Highest Credit Rating during the previous FY D 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Shweta Patel Designation: Company Secretary and Compliance Officer EmailId: cs@mangalamdrugs.com Name of the Chief Financial Officer: Jeevan Dalvi Designation: Chief Fianancial Officer EmailId: jdalvi@mangalamdrugs.com Date: 28/09/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

• BSE India
• 3 days 7 hours ago

Intimation for Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading)Regulations, 2015 for the quarter ended September 30, 2026

• BSE India
• 6 days 7 hours ago